(Q38115369)

29 August 2017

title

Systematic review of pneumococcal disease costs and productivity loss studies in Latin America and the Caribbean (English)

1 reference

29 August 2017

1 reference

2

Cristiana M Toscano

1 reference

29 August 2017

Luciana Bahia

1

1 reference

29 August 2017

Maíra Libertad Soligo Takemoto

series ordinal

3

1 reference

29 August 2017

Denizar Vianna Araujo

series ordinal

4

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

31 Suppl 3

1 reference

29 August 2017

page(s)

C33-44

1 reference

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Estimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Custos hospitalares da meningite causada por Streptococcus pneumoniae na cidade de São José dos Campos, São Paulo, Brasil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the universal immunisation of infants in Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Childhood pneumococcal disease burden in Argentina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

[The economic costs of pneumonia in children under 2 years of age in Colombia]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae-associated disease following vaccination with PCV-7: a multicountry analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

[Economic evaluation of an infant immunization program in Mexico, based on 13-valent pneumococcal conjugated vaccines].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Direct medical costs of invasive pneumococcal disease and radiologically-diagnosed pneumonia among Chilean children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Evaluating the costs of pneumococcal disease in selected Latin American countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Economic impact of pneumococcal conjugate vaccination in Brazil, Chile, and Uruguay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.030

10.1016/J.VACCINE.2013.05.030

7 January 2021

Identifiers

DOI

1 reference

29 August 2017

1 reference